Qureight
Qureight is a UK-based healthcare AI and clinical data analytics company that operates as an end-to-end imaging contract research organization (CRO). Its proprietary, cloud-based platform curates clinical imaging and associated healthcare data and applies AI analysis to generate imaging and precision endpoints for biopharmaceutical clinical trials. The company focuses primarily on lung and heart diseases, including idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, pulmonary hypertension and bronchiectasis, working with biopharma companies, contract research organizations and healthcare institutions to accelerate drug development and improve clinical-trial decision-making. Its market position is as a specialist AI-enabled imaging and precision-endpoint provider for cardiopulmonary clinical research, rather than a consumer healthcare or general-purpose medical AI company.
Company Details
- Website
- qureight.com
- Headquarters
- Cambridge, England, United Kingdom
- Founded
- 2018
- Funding
- Approximately $30.5M disclosed across seed, Series A and Series B rounds; reported amounts include $
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring